Molecular Partners AG ( MOLN) - Key Metrics
MOLN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.36 | -$0.28 | -$0.28 |
| 2026Q1 | $0 | -$0.35 | -$0.39 | -$0.39 |
| 2025Q4 | $0 | -$0.42 | -$0.36 | -$0.36 |
| 2025Q3 | $0 | -$0.40 | -$0.34 | -$0.34 |
| 2025Q2 | $0 | -$0.55 | -$0.35 | -$0.35 |
MOLN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.23 |
| 2026Q1 | 0% | -2.27 |
| 2025Q4 | 0% | -2.62 |
| 2025Q3 | 0% | -2.30 |
| 2025Q2 | 0% | -1.38 |
MOLN
Price: $3.96
52 week price:
Earnings Per Share: -1.68 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 4126
Market Capitalization: 163.2 million